PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer.
Sfakianaki M, Papadaki C, Tzardi M, Trypaki M, Manolakou S, Messaritakis I, Saridaki Z, Athanasakis E, Mavroudis D, Tsiaoussis J, Gouvas N, Souglakos J.
Sfakianaki M, et al. Among authors: mavroudis d.
Cancers (Basel). 2020 Jul 25;12(8):2058. doi: 10.3390/cancers12082058.
Cancers (Basel). 2020.
PMID: 32722474
Free PMC article.